Related Disciplines > Surgery

You are looking at 91 - 92 of 92 items

I Huguet Departments of Endocrinology

Search for other papers by I Huguet in
Google Scholar
PubMed
Close
,
C Lamas Departments of Endocrinology

Search for other papers by C Lamas in
Google Scholar
PubMed
Close
,
R Vera Pathology, University Hospital Complex, Albacete, Spain

Search for other papers by R Vera in
Google Scholar
PubMed
Close
,
A Lomas Departments of Endocrinology

Search for other papers by A Lomas in
Google Scholar
PubMed
Close
,
R P Quilez Departments of Endocrinology

Search for other papers by R P Quilez in
Google Scholar
PubMed
Close
,
A Grossman OCDEM, Churchill Hospital, Oxford, UK

Search for other papers by A Grossman in
Google Scholar
PubMed
Close
, and
F Botella Departments of Endocrinology

Search for other papers by F Botella in
Google Scholar
PubMed
Close

Summary

Neuroendocrine tumours (NETs) are a heterogeneous group of neoplasms whose management can be problematic. In many cases, multiple tumours may occur in the same patient or his or her family, and some of these have now been defined genetically, although in other cases the underlying gene or genes involved remain unclear. We describe a patient, a 63-year-old female, who was diagnosed with a medullary thyroid carcinoma (MTC), which was confirmed pathologically after thyroidectomy, but whose circulating calcitonin levels remained elevated after thyroidectomy with no evidence of metastatic disease. Subsequently, an entirely separate and discrete duodenal NET was identified; this was 2.8 cm in diameter and was removed at partial duodenectomy. The tumour stained immunohistochemically for calcitonin, and its removal led to persistent normalisation of the circulating calcitonin levels. There was no germline mutation of the RET oncogene. This is the first identification of a duodenal NET secreting calcitonin and also the first demonstration of a second tumour secreting calcitonin in a patient with MTC. We suggest that where calcitonin levels remain high after removal of a MTC a search for other NETs should be conducted.

Learning points

  • NETs are a complex and heterogeneous group of related neoplasms, and multiple tumours may occur in the same patient.

  • Calcitonin can be produced ectopically by several tumours outside the thyroid.

  • Persistently elevated calcitonin levels after removal of a MTC may not necessarily indicate persisting or metastatic disease from the tumour.

  • The real prevalence of calcitonin-producing NETs may be underestimated, as serum determination is only recommended in the diagnosis of pancreatic NETs.

Open access
Deep Dutta Departments of Endocrinology and Metabolism

Search for other papers by Deep Dutta in
Google Scholar
PubMed
Close
,
Chitra Selvan Departments of Endocrinology and Metabolism

Search for other papers by Chitra Selvan in
Google Scholar
PubMed
Close
,
Manoj Kumar Departments of Endocrinology and Metabolism

Search for other papers by Manoj Kumar in
Google Scholar
PubMed
Close
,
Saumik Datta Departments of Endocrinology and Metabolism

Search for other papers by Saumik Datta in
Google Scholar
PubMed
Close
,
Ram Narayan Das Pathology, IPGMER and SSKM Hospital, Room-9A, 4th Floor Ronald Ross Building, 244 AJC Bose Road, Calcutta 700020, India

Search for other papers by Ram Narayan Das in
Google Scholar
PubMed
Close
,
Sujoy Ghosh Departments of Endocrinology and Metabolism

Search for other papers by Sujoy Ghosh in
Google Scholar
PubMed
Close
,
Satinath Mukhopadhyay Departments of Endocrinology and Metabolism

Search for other papers by Satinath Mukhopadhyay in
Google Scholar
PubMed
Close
, and
Subhankar Chowdhury Departments of Endocrinology and Metabolism

Search for other papers by Subhankar Chowdhury in
Google Scholar
PubMed
Close

Summary

Parathyroid cysts are rare (0.8–3.41% of all parathyroid lesions) and usually arise secondary to cystic degeneration of parathyroid adenomas. Intrathyroidal parathyroid cysts are extremely rare with only three cases reported till date. We present a 24-year-old female with clinical and biochemical features of primary hyperparathyroidism (PHPT; Ca2 +: 12.1 mg/dl; intact parathyroid hormone (iPTH): 1283 pg/ml) and poor radiotracer uptake with minimal residual uptake in the left thyroid lobe at 2 and 4 h on Tc99m sestamibi imaging. Neck ultrasonography (USG) revealed 0.6×1 cm parathyroid posterior left lobe of thyroid along with 22×18 mm simple thyroid cyst. USG-guided fine-needle aspiration (FNA) and needle tip iPTH estimation (FNA-iPTH) from parathyroid lesion was inconclusive (114 pg/ml), necessitating FNA of thyroid cyst, which revealed high iPTH (3480 pg/ml) from the aspirate. The patient underwent a left hemithyroidectomy. A >50% drop in serum iPTH 20 min after left hemithyroidectomy (29.4 pg/ml) along with histopathology suggestive of intrathyroidal cystic parathyroid adenoma (cystic lesion lined by chief cell variant parathyroid cells without any nuclear atypia, capsular or vascular invasion surrounded by normal thyroid follicles) confirmed that the parathyroid cyst was responsible for PHPT. This report highlights the importance of FNA-iPTH in localizing and differentiating a functional parathyroid lesion from nonfunctional tissue in PHPT.

Learning points

  • Fine-needle aspiration from suspected parathyroid lesion and needle tip iPTH (FNA-iPTH) estimation from the saline washing has an important role in localizing primary hyperparathyroidism (PHPT).

  • FNA-iPTH estimation may help in differentiating functional from nonfunctional parathyroid lesion responsible for PHPT.

  • iPTH estimation from aspirate of an intrathyroid cyst is helpful in differentiating intrathyroidal parathyroid cyst from thyroid cyst.

Open access